Search Results
Dec 02, 2025, 08:32 ET McCollum Heritage 91 Announces Participation in the One Barrel Challenge with Adelsheim Vineyard
2021 Pinot Noir reveals layers of roasted hazelnut, red licorice, and cocoa powder. Silky tannins and a velvety core lend depth and finesse to this age-worthy Chehalem Mountains classic.The One Barrel Challenge Wines are available in limited quantities, offering wine enthusiasts a meaningful
More news about: McCollum Heritage 91
Dec 02, 2025, 08:15 ET AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly diagnosed acute myeloid leukemia (AML) who: ‒ are 75 years of age or older, or ‒ have other medical conditions that prevent the use of standard chemotherapy.It is not known if VENCLEXTA is safe
More news about: AbbVie Inc.
Dec 02, 2025, 08:00 ET Orsini Selected as Specialty Pharmacy Partner for ITVISMA® (onasemnogene abeparvovec-brve)
abeparvovec-brve), an FDA-approved intrathecal gene therapy for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in SMN1 gene. Read the full Prescribing Information
More news about: Orsini
Dec 02, 2025, 08:00 ET Actor Neal McDonough Marks First Year with Flip My Life Wellness
nutritionists, product scientists, medical experts, and industry innovators, strengthening Flip My Life's position as a legacy brand for helping people age better through a nutritional lifestyle. Together with his wife, Ruvé, McDonough is helping to build a positive brand culture and a like-minded community
More news about: Flip My Life Wellness
Dec 02, 2025, 08:00 ET Clairity Unites Pioneers In Medicine And Technology To Redefine Predictive AI For Human Health
to every woman's care."Why It MattersBreast cancer remains the most common cancer in women. Traditional risk tools often rely on age, family history, or breast density—factors that leave many women misclassified. Clairity's AI uses the mammogram itself to generate a calibrated, individualized
More news about: Clairity
Dec 02, 2025, 08:00 ET Sigma Squared Named to Inc.'s Best in Business List for Best AI Implementation, Capping Breakout Year of Product Innovation
model undergoes automated and human-reviewed bias-testing to ensure models never rely on traits that act as proxies for protected classes such as race, age, or gender.Over the past year, organizations using QualFit have also reported:19% increase in team output using QualFit-guided
More news about: Sigma Squared
Dec 02, 2025, 08:00 ET EY US identifies eight health trends for 2026: transforming operations, talent and finance
understand the implications of today's trends, proactively finding solutions to business issues and to seize the upside of disruption in this transformative age.
More news about: EY
Dec 02, 2025, 08:00 ET NAMM Announces Comprehensive Schedule for The 2026 NAMM Show
ideas shaping the future of recording studios Mixing a Hit: Andrew Scheps on Hozier's "Too Sweet" The Evolution of Sampling in the Age of AI Sound for Picture Workshop: Licensing From the Music Supervisor's Chair ENTERTAINMENT TECHNOLOGY TRACK Programs:
More news about: NAMM (National Association of Music Merchants)
Dec 02, 2025, 07:00 ET Yardi Launches Yardi MH Manager for Institutional Manufactured Housing Operators
A new all-in-one enterprise solution aims to resolve age-old issues in community managementSANTA BARBARA, Calif., Dec. 2, 2025 /PRNewswire/ -- Yardi® is
More news about: Yardi
Dec 02, 2025, 07:00 ET Kumo Honored on Inc. Magazine's Best in Business List for 2025
large language models reshaped unstructured text, Kumo set out to bring structured data, the core and differentiating asset of every company, into the age of AI.With KumoRFM, users are able to take their relational data that was simply sitting in their systems and turn it into something that moves
More news about: Kumo.AI
Dec 02, 2025, 07:00 ET Disneyland Resort 70th Celebration Continues in 2026 with Debut of "Bluey's Best Day Ever!," Limited-Time Events and More
terminated at any time.Children should be supervised. Guests under age 14 must be accompanied by a Guest age 14 or older to enter a Theme Park. To board an attraction, children under age 7 must be accompanied by a person age 14 years or older. Other park rules apply. To enter a park, both a theme
More news about: Disneyland Resort
Dec 02, 2025, 07:00 ET TNL Mediagene Hosts 2025 Becoming Aces Awards and Launches "Rising Star in Digital Impact" with 91APP Foundation to Advance Youth Innovation and Sustainable Impact
https://91app.org.tw/about-us/About Becoming AcesBecoming Aces is a platform officially launched by TNL Mediagene in 2015. We seek out young talents under the age of 35 who are changing the society in their own specialized areas. Through the power of the media, we present their stories and help amplify their dreams
More news about: TNL Mediagene
Dec 02, 2025, 06:40 ET Prescription Drugs Market Poised for Substantial Growth, Driven by Novel Therapies and Evolving Regulatory Landscape: Reaching US$2.15 Trillion by 2032
US$111.6 billion, representing a substantial share of the global market. The market growth is consistently driven by demand for advanced treatments for age-related disorders and the efficient uptake of biosimilars.Latest News, Mergers, and Acquisitions:November 2025 the Japanese regulatory
More news about: DataM Intelligence 4 Market Research LLP
Dec 02, 2025, 05:45 ET Four Seasons Education Reports First Half of Fiscal Year 2026 Unaudited Financial Results
school-based tutoring product solutions and training programs for teachers, study camps and learning trips for students, and travel agency services for all age groups. For more information, please visit https://ir.sijiedu.com.About
More news about: Four Seasons Education Inc.
Dec 02, 2025, 04:00 ET Ziwig Endotest®: Scientific Validation Published in NEJM Evidence
to diagnosis.A major advance for women's healthEndometriosis affects around 10% of women of reproductive age, with diagnostic delays often exceeding seven years. The validation and clinical deployment of Ziwig Endotest® mark a major step forward toward earlier,
More news about: Ziwig
Dec 02, 2025, 04:00 ET Prezzee Brings AI-Powered Magic to the Holidays with Free Santa and Carolers Experiences
personally. Kids will love the magic of hearing Santa say they made the "Nice List" by name. Creating this experience is simple - just add a child's name and age, and let AI do the rest. And, the video can be easily paired with a special-edition Prezzee gift card.The Magical Christmas Carolers experience
More news about: Prezzee
Dec 02, 2025, 03:49 ET Partenariat entre l'UNICEF et Rönesans pour transformer la formation professionnelle des jeunes en Turquie
aux exigences de leur époque. »Façonner l'avenirLa Turquie est confrontée à une difficulté d'ampleur : près d'un jeune sur quatre âgé de 15 à 24 ans ne suit pas d'études, n'a pas d'emploi ou n'est pas en formation. Le programme « De l'apprentissage au revenu pour la jeunesse » s'attaque
More news about: Rönesans Holding
Dec 02, 2025, 03:23 ET À l'occasion du 19e Congrès européen sur les céphalées, AbbVie va présenter les données de la phase 3 d'ECLIPSE démontrant la supériorité de l'atogépant (AQUIPTA®) par rapport au placebo dans le soulagement complet de la douleur pour le traitement aigu de la migraine
insuffisance hépatique sévère.Fertilité, grossesse et allaitementAQUIPTA n'est pas recommandé pendant la grossesse ni chez les femmes en âge de procréer qui n'utilisent pas de contraception.Effets sur l'aptitude à conduire et à utiliser des machinesAQUIPTA n'a aucune influence
More news about: AbbVie
Dec 02, 2025, 03:00 ET La précision de Ziwig Endotest® est confirmée par ENDOmiRNA, la plus grande étude mondiale menée sur un biomarqueur salivaire dans le diagnostic de l'endométriose
facteurs géographiques ou temporels (centre d'inclusion, délai d'expédition, délai de séquençage de l'ARN) ni par les caractéristiques des patientes (âge, présence ou non d'endométriose, stade de l'endométriose, prise ou non d'un traitement hormonal ou antalgique).L'étude démontre également l'utilité
More news about: Ziwig
Dec 02, 2025, 02:27 ET Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
Program). The FDA has granted Breakthrough Therapy designation for bexicaserin for the treatment of seizures associated with DEEs for patients two years of age and older. Bexicaserin has also recently been granted Breakthrough Therapy Designation in China for the treatment of seizures associated with DEEs.About
More news about: H. Lundbeck A/S
Dec 02, 2025, 02:25 ET Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
Program). The FDA has granted Breakthrough Therapy designation for bexicaserin for the treatment of seizures associated with DEEs for patients two years of age and older. Bexicaserin has also recently been granted Breakthrough Therapy Designation in China for the treatment of seizures associated with DEEs.About
More news about: H. Lundbeck A/S
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
people globally, with around one in three women and one in five men over 50 years experiencing osteoporotic fractures in their lifetime. As populations age, the prevalence and economic impact of osteoporosis are expected to continue rising, placing additional pressure on healthcare systems.OSVYRTI
More news about: Accord Healthcare
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
people globally, with around one in three women and one in five men over 50 years experiencing osteoporotic fractures in their lifetime. As populations age, the prevalence and economic impact of osteoporosis are expected to continue rising, placing additional pressure on healthcare systems.OSVYRTI
More news about: Accord Healthcare
Dec 02, 2025, 00:30 ET The Martech Reset: Lessons from 2025 That Will Shape How CMOs Invest in 2026, opines Kalpit Jain, CEO, Netcore Cloud
and buy for them. Products are no longer discovered only by people but also by machines acting on their behalf.What 2026 Will Look Like: The Age of Agentic CustomersGartner predicts that by 2026, 20% of all sales will come from AI-powered buyers, machines that search, compare,
More news about: Netcore Cloud
Dec 01, 2025, 23:59 ET AbbVie präsentiert auf dem 19. European Headache Congress Phase-3-Daten aus der ECLIPSE-Studie, die die Überlegenheit von Atogepant (AQUIPTA®) gegenüber Placebo bei der Schmerzlinderung in der Akutbehandlung von Migräne belegen
Headache Congress 2025.2 Dong L, Dong W, Jin Y, et al. The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region. Pain and Therapy. 2025;14(1):297-315.3 What is Migraine. The Migraine Trust. Verfügbar auf:
More news about: AbbVie